Radix puerariae extracts may rise in the future
date:2014-05-16
browse:(1139)
Keyword:
Radix puerariae tablet mainly derived from wild resources as raw materials for the extraction. Due to its strong ability of regeneration, the market supply of radix puerariae is adequate, but which of high content is dwindling. Thus, the cost of it extract is increasingly high.
Although sales volume of puerarin is increased year by year from 2000 to 2007, the price is reduced, puerarin which content is the 99.5% from the highest 20000 yuan/Kg drop to 1500 yuan/Kg now; since 2007,the sales of pueraria flavonoid had stable growth each year, but the market prices has little change. For example, take the ultraviolet detection of 40% pueraria flavones. In recent years, with the extraction process of improvement, raw material cost of it has rise constantly, while price has been steadily even dropped.
common specifications and applications of radix puerariae extracts
Specification detection method applications
40% pueraria flavones UV / HPLC the raw materials of health products that lowering blood pressure, blood sugar and blood fat
80% pueraria flavones UV / HPLC the raw material that can alternative pueraria medicinal herbs
15% puerarin HPLC Gegen Qinlian Tablets,
Kudzu root medicine alcohol extract
30% puerarin HPLC Estrogen-containing highest specifications,
Can be used for menopausal women health care
The latest article
- White Paper on Bone and Joint Health of Chinese Consumers 2020
- Yili Dairy launched high-protein yogurt, focusing on sport people
- Sinopharm Xingsha launched the Japan's Champion probiotics
- China has introduced its first policy to support the industrial hemp industry
- Beyond Meat became the first overseas Artificial Meat company to set up a factory in China
- Nongfu Spring's market value exceeded HK $370 billion on its first day
- German infant nutrition brand Amykon launched two probiotics in China
- The revenue of Besunyoung in the first half year is about 610 million yuan
- Jellly candy and powder included in the health food filing dosage form in China
- H&H Group net profit increased by 9% for the first half of year